Searched for
MARCK BIOSCIENCES LTD.
USFDA issues warning to Indian drug maker Marck BiosciencesMarck Biosciences, now known as Amanta Healthcare received warning letter by US drug authority. USFDA found flase data and dead & decaying ...- Indian companies among firms yet to pay annual facility fees to FDAFDA has named at least five Indian companies among 43 drugmakers that have failed to meet their annual facility fee payment obligations.
- Tata Capital buys 19% stake in Marck BiosciencesThe Fund Infusion from Tata Capital will be invested for further expansion of capacities of the new project which will have state of the ar...
- South Africa approves six Marck Biosciences pharma productsThe South African market worth around $ 3.8 billion (2011), is growing at the rate of six per cent and is expected to reach $ 7 billion by ...
- South Africa drug authority approves Marck's 6 productsSix products have obtained approvals from MCC-South Africa, including Sterile Water for injections and Ciprofloxacin Eye Drops among others.
- Volatile market takes toll on Pharmaceuticals and healthcare IPO plansThe market has hit the IPO plans of pharma and healthcare companies with several firms either withdrawing or deferring their offers.
- Micromax, Pride Hotels among IPOs expired in Jan 2012Four IPOs, including that of Micromax Mobiles and Pride Hotels, have expired in January 2012, Tara Jewels and Betul Oil being the other two.
- Intas gets SEBI nod for IPO for raising Rs 800 croreIntas Pharmaceuticals has received SEBI clearance for its IPO. The issue was expected to hit the market in May, but Intas is still undecide...
- IVCF lines up Rs 100cr investment for startupsIFCI Venture Capital Funds (IVCF), the venture capital arm of IFCI, is planning to invest Rs 100 crore in startups over the next nine month...
- Marck Biosciences plans to enter Latin American marketDrug manufacturer Marck Biosciences is planning to enter the Latin American market and has got the nod from the Brazilian healthcare watchd...
Load More- South Africa approves six Marck Biosciences pharma products
